Therapeutic challenges of attention-deficit hyperactivity disorder with substance use disorders

References

• Barkley R. Attention-deficit hyperactivity disorder, In: A handbook for diagnosis and treatment, Third Edition.Guilford Press, NY, USA (2005).
   Google Scholar
• Weiss G, Hechtman L, Milroy T, Perlman T. Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. J. Am. Acad. Child Adolesc. Psychiatry24, 211–220 (1985).
   Web of Science ®Google Scholar
• Barkley RA, Biederman J. Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry36, 1204–1210 (1997).
   PubMed Web of Science ®Google Scholar
• Bukstein OG, American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children and adolescents with substance use disorders. J. Am. Acad. Child Adolesc. Psychiatry44, 609–621 (2005).
   PubMed Web of Science ®Google Scholar
• Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry62(6), 617–627 (2005).
   PubMed Web of Science ®Google Scholar
• Levin FR, Evans SM, McDowell DM. Methylphenidate treatment for cocaine abusers with adult attention-deficit hyperactivity disorder: a pilot study. J. Clin. Psychiatry59, 300–305 (1998).
   PubMed Web of Science ®Google Scholar
• King VL, Brooner RK, Kidorf MS. Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment. J. Nerv. Ment. Dis.187, 487–495 (1999).
   PubMed Web of Science ®Google Scholar
• Schubiner H, Tzelepis A, Milberger S. Prevalence of attention-deficit hyperactivity disorder and conduct disorder among substance abusers. J. Clin. Psychiatry61, 244–251 (2000).
   PubMed Web of Science ®Google Scholar
• DeMilio L. Psychiatric syndromes in adolescent substance abusers. Am. J. Psychiatry146, 1212–1214 (1989).
   PubMed Web of Science ®Google Scholar
• Milin R, Halikas JA, Meller JE et al. Psychopathology among substance abusing juvenile offenders. J. Am. Acad. Child Adolesc. Psychiatry30(4), 569–574 (1991).
   PubMed Web of Science ®Google Scholar
• Molina BSG, Bukstein OG, Lynch KG. ADHD and conduct disorder symptomatology in adolescents with alcohol use disorder. Psychol. Addict. Behav.16(2), 161–164 (2002).
   PubMed Web of Science ®Google Scholar
• Thompson LL, Riggs PD, Mikulich SK et al. Contribution of ADHD symptoms to substance problems and delinquency in conduct-disordered adolescents. J. Abnorm. Child Psychol.24, 325–347 (1996).
   PubMed Web of Science ®Google Scholar
• Goodwin DW, Schulsinger F, Hermansen L et al. Alcoholism and the hyperactive child syndrome. J. Nerv. Ment. Dis.160(5), 349–353 (1975).
   PubMed Web of Science ®Google Scholar
• Wilens T, Spencer T, Biederman J. Are attention-deficit/hyperactivity disorder and the psychoactive substance use disorders really related? Harv. Rev. Psychiatry3, 260–262 (1995).
   Google Scholar
• Mannuzza S, Klein RG, Bessler A et al. Adult psychiatric status of hyperactive boys grown up. Am. J. Psychiatry155, 493–498 (1998).
   PubMed Web of Science ®Google Scholar
• Hechtman L, Weiss G. Controlled prospective fifteen year follow-up of hyperactives as adults: nonmedical drug and alcohol use and anti-social behaviour. Can. J. Psychiatry31, 557–567 (1986).
   PubMed Web of Science ®Google Scholar
• Biederman J, Monuteaux MC, Mick E et al. Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol. Med.36, 167–179 (2006).
   PubMed Web of Science ®Google Scholar
• Schubiner H, Tzelepis A, Milberger S et al. Prevalence of ADHD and conduct disorder among substance abusers. J. Clin. Psychiatry61, 244–251 (2000).
   PubMed Web of Science ®Google Scholar
• Wilens T. Alcohol and other drug use and attention-deficit/hyperactivity disorder. Alcohol Health Res. World22(2), 127–130 (1998).
   PubMedGoogle Scholar
• Wilens TE, Biederman J, Mick E et al. Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders. J. Nerv. Ment. Dis.185, 475–482 (1997).
   PubMed Web of Science ®Google Scholar
• McGough JJ, Smalley SL, McCracken JT et al. Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. Am. J. Psychiatry162(9), 1621–1627 (2005).
   PubMed Web of Science ®Google Scholar
• Carroll KM, Rounsaville BJ. History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr. Psychiatry34, 75–82 (1993).
   PubMed Web of Science ®Google Scholar
• Levin FR, Evans SM, McDowell D, Kleber HD. Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study. J. Clin. Psychiatry58, 1–21 (1997).
   PubMedGoogle Scholar
• Barkley RA, Fischer M, Smallish L, Fletcher K. Young adult follow-up of hyperactive children: antisocial activities and drug use. J. Child Psychol. Psychiatry45, 195–211 (2004).
   PubMed Web of Science ®Google Scholar
• Gittelman R, Mannuzza S, Shenker R, Bonagura N. Hyperactive boys almost grown up, I: psychiatric status. Arch. Gen. Psychiatry42, 937–947 (1985).
   PubMed Web of Science ®Google Scholar
• Lynskey MT, Fergusson DM. Childhood conduct problems and attention deficit behaviours and adolescent alcohol, tobacco and illicit drug use. J. Abnorm. Child Psychol.23, 281–302 (1995).
   PubMed Web of Science ®Google Scholar
• Disney ER, Elkins IJ, McGue M et al. Effects of ADHD, conduct disorder, and gender on substance use and abuse in adolescence. Am. J. Psychiatry156, 1515–1521 (1999).
   PubMed Web of Science ®Google Scholar
• Greenbaum PE, Prange ME, Friedman RM et al. Substance abuse prevalence and comorbidity with other psychiatric disorders among adolescents with severe emotional disturbances. J. Am. Acad. Child Adolesc. Psychiatry30, 575–583 (1991).
   PubMed Web of Science ®Google Scholar
• Molina BSG, PelhamWE. Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J. Abnorm. Psychol.112(3), 497–507 (2003).
   PubMed Web of Science ®Google Scholar
• Loeber R, Brinthaupt VP, Green SM. Attention deficits, impulsivity, and hyperactivity with or without conduct problems: relationships to delinquency and unique contextual factors. In: Behavior Disorders of Adolescence: Research, Intervention, and Policy in Clinical and School Settings. McMahon RJ, Peters RD (Eds). Plenum, NY, USA. 39–61 (1990).
   Google Scholar
• Moffitt TE. Juvenile delinquency and attention deficit disorder: boys developmental trajectories from age 3 to age 15. Child Dev.61, 893–910 (1990).
   PubMed Web of Science ®Google Scholar
• Adler L, Cohen J. Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatr. Clin. North Am.27, 187–201 (2004).
   PubMed Web of Science ®Google Scholar
• Collett BR, Ohan JL, Myers KM. Ten-year review of rating scales. v: scales assessing attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry42(9), 1015–1037 (2003).
   PubMed Web of Science ®Google Scholar
• Conners CK, Erhardt JN, Epstein D et al. Conners adult self-rating of ADHD symptoms in adults I: factor structure and normative data.J. Atten. Disord.3(3), 141–151 (1999).
   Google Scholar
• Millstein RB, Wilens TE, Biederman J, Spencer TJ. Presenting ADHD symptoms and subtypes in clinically referred adult with ADHD.J. Atten. Disord.2, 159–166 (1997).
   Google Scholar
• Wilens TE, Haight BR, Horrigan JP et al. Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. Biol. Psychiatry57(7), 793–801 (2005).
   PubMed Web of Science ®Google Scholar
• Spencer T, Biederman J, Wilens T. Stimulant treatment of adult attention-deficit/hyperactivity disorder. Psychiatr. Clin. North Am.27(2), 361–372 (2004).
   PubMedGoogle Scholar
• Robbins TW, Everitt BJ. Drug addiction: bad habits add up. Nature398, 567–570 (1999).
   PubMed Web of Science ®Google Scholar
• Huss M, Lehmkuhl U. Methylphenidate and substance abuse: a review of pharmacology, animal and clinical studies.J. Atten. Disord.6, 565–571 (2002).
   Google Scholar
• Kollins SH, MacDonald EK, Rush CR. Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review. Pharmacol. Biochem. Behav.68, 611–627 (2001).
   PubMed Web of Science ®Google Scholar
• Volkow ND, Ding Y, Fowler JS et al. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch. Gen. Psychiatry52, 456–463 (1995).
   PubMed Web of Science ®Google Scholar
• Volkow N, Wang G, Fowler J et al. Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addictions. Am. J. Psychiatry156(1), 19–26 (1999).
   PubMed Web of Science ®Google Scholar
• Volkow ND, Wang GJ, Fowler JS et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in human brain. J. Neurosci.21, 1–5 (2001).
   Web of Science ®Google Scholar
• Volkow ND, Wang GJ, Fowler JS et al. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine. Therapeutic implications. Synapse43(3), 181–187 (2002).
   PubMed Web of Science ®Google Scholar
• Volkow ND, Wang GJ, Fowler JS et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am. J. Psychiatry155, 1325–1331 (1998).
   PubMed Web of Science ®Google Scholar
• Jaffe SL. Failed attempts at intranasal abuse of concerta. J. Am. Acad. Child Adolesc. Psychiatry41(1), 5 (2002).
   PubMed Web of Science ®Google Scholar
• Ciccone PE. Attempted abuse of Concerta®. J. Am. Acad. Child Adolesc. Psychiatry41, 756 (2002).
   PubMedGoogle Scholar
• Grabowski J, Roache JD, Schmitz JM, Rhoades H, Creson D, Korszun A. Replacement medication for cocaine dependence. Methylphenidate. J. Clin. Psychopharmacol.17(6), 485–488 (1997).
   PubMed Web of Science ®Google Scholar
• Shearer J, Wodak A, Mattick R et al. Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence. Addiction96, 1289–1296 (2001).
   PubMed Web of Science ®Google Scholar
• Michelson D, Adler L, Spencer T et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol. Psychiatry53, 112–120 (2003).
   PubMed Web of Science ®Google Scholar
• Michelson D, Allen AJ, Busner J et al. Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am. J. Psychiatry159, 1896–1901 (2002).
   PubMed Web of Science ®Google Scholar
• Bymaster FP, Katner JS, Nelson DL et al. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy inattention deficit/hyperactivity disorder. Neuropsychopharmacology27, 699–711 (2002).
   PubMed Web of Science ®Google Scholar
• Heil SH, Holmes HW, Bickel WK et al. Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users. Drug Alcohol Depend.67(2), 149–156 ( 2002).
   PubMedGoogle Scholar
• Davidson JT, Connor KM. Bupropion sustained release: a therapeutic overview. J. Clin. Psychiatry58(Suppl. 4), 25–31 (1998).
   Google Scholar
• Ferris RM, Cooper BR, Maxwell RA. Studies of bupropion’s mechanism of antidepressant activity.J. Clin. Psychiatry44, 74–78 (1983).
   PubMed Web of Science ®Google Scholar
• Griffith JD, Carranza J, Griffith C, Miller LI. Bupropion: clinical essay for amphetamine-like potential. J. Clin. Psychiatry44, 206–208 (1983).
   PubMed Web of Science ®Google Scholar
• Hurt RD, Sachs PPL, Glover ED et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N. Engl. J. Med.337, 1195–1202 (1997).
   PubMed Web of Science ®Google Scholar
• Goldstein MG. Bupropion sustained release and smoking cessation.J. Clin. Psychiatry59, 66–72 (1998).
   PubMedGoogle Scholar
• Dackis CA, Lynch KG, Yu E et al. Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. Drug Alcohol Depend.70, 29–37 (2003).
   PubMed Web of Science ®Google Scholar
• Turner DC, Robbins TW, Clark L et al. Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology165, 260–269 (2003).
   PubMed Web of Science ®Google Scholar
• Turner DC, Clark L, Dowson J et al. Modafinil improves cognition and response inhibition in adult attention deficit/hyperactivity disorder. Biol. Psychiatry55, 1031–1040 (2004).
   PubMed Web of Science ®Google Scholar
• Dackis CA, Kampman KM, Lynch KG et al. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology30, 205–211 (2005).
   PubMed Web of Science ®Google Scholar
• Rugino TA, Copley TC. Effects of modafinil in children with attention-deficit/hyperactivity disorder: an open-label study. J. Am. Acad. Child Adolesc. Psychiatry40(2), 230–235 (2001).
   PubMed Web of Science ®Google Scholar
• Biederman J, Swanson JM, Wigal SB et al. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study. Pediatrics116, E777–E784 (2005).
   PubMed Web of Science ®Google Scholar
• Swanson JM, Greenhill LL, Lopez FA et al. Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation. J. Clin. Psychiatry67, 137–147 (2006).
   PubMed Web of Science ®Google Scholar
• Myrick H, Malcolm R, Taylor B, LaRowe S. Modafinil: preclinical, clinical, and post-marketing surveillance–a review of abuse liability issues. Ann. Clin. Psychiatry16(2), 101–109 (2004).
   PubMedGoogle Scholar
• Johnston L, O’Malley P, Bachman J. Monitoring the Future National Survey Results on Drug Use, 1975–2000. Vol. I: Secondary School Students NIH Publication No. 01–4924, National Institute on Drug Abuse, MD, USA (2001).
   Google Scholar
• Indiana Prevention Resource Center Survey. Alcohol, Tobacco, and Other Drug Use by Indiana Children and Adolescents Bloomington, IN. Indiana University, USA (1998).
   Google Scholar
• Addiction Research Foundation. The Ontario Study Drug Use Survey: 1977–1995 Toronto, Ontario. Arkansas, Canada. (1995).
   Google Scholar
• Gordon SM, Tulak F, Troncale J. Prevalence and characteristics of adolescents patients with co-occurring ADHD and substance dependence. J. Addict. Dis.23(4), 31–40 (2004).
   PubMed Web of Science ®Google Scholar
• Williams RJ, Goodale LA, Shay-Fiddler MA, Gloster SP, Chang SY. Methylphenidate and dextroamphetamine abuse in substance-abusing adolescents. Am. J. Addict.13(4), 381–389 (2004).
   PubMed Web of Science ®Google Scholar
• McCabe SE, Teter CJ, Boyd CJ. The use, misuse and diversion of prescription stimulants among middle and high school students. Subst. Use Misuse39, 1095–1116 (2004).
   Google Scholar
• McCabe SE, Knight JR, Teter CJ, Wechsler H. Nonmedical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction100, 96–106 (2005).
   PubMed Web of Science ®Google Scholar
• Teter CJ, McCabe SE, Cranford JA, Boyd CJ, Guthrie SK. Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample. J. Am. Coll. Health53, 253–262 (2005).
   PubMed Web of Science ®Google Scholar
• McCabe SE, Boyd CJ. Sources of prescription drugs for illicit use. Addcit. Behav.30, 1342–1350 (2005).
   PubMed Web of Science ®Google Scholar
• National Institute on Drug Abuse (NIDA) Community Epidemiology Work Group (CEWG). Epidemiologic Trends In Drug Abuse.NIH, Washington, DC, USA (1995).
   Google Scholar
• Jaffe SL. Intranasal abuse of prescribed methylphenidate by an alcohol and drug abusing adolescent with ADHD. J. Am. Acad. Child Adolesc. Psychiatry30, 773–775 (1991).
   PubMed Web of Science ®Google Scholar
• Wilens TE, Faraone SV, Biederman J et al. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics111, 179–185 (2003).
   PubMed Web of Science ®Google Scholar
• Faraone SV, Wilens T. Does stimulant treatment lead to substance use disorders? J. Clin. Psychiatry64(Suppl. 11), 9–13 (2003).
   PubMed Web of Science ®Google Scholar
• Biederman J, Wilens T, Mick E et al. Is ADHD a risk for psychoactive substance use disorder? Findings from a four-year follow-up study. J. Am. Acad. Child Adolesc. Psychiatry36, 21–29 (1997).
   PubMed Web of Science ®Google Scholar
• Pelham WE, Molina BS, Meichenbaum D, Gnagy E, Greenhouse J. Stimulant effects on long term outcomes in ADHD individuals. Presentation at: 43rd Annual New Clinical Drug Evaluation Unit Meeting, Boca Raton, FL, USA (2003).
   Google Scholar
• Levin FR, Evans SM, Brooks DJ et al. Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo. Drug Alcohol Depend.81, 137–148 (2006).
   PubMed Web of Science ®Google Scholar
• Riggs PD, Hall SK, Mikulich-Gilbertson SK, Lohman M, Kayser A. A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents. J. Am. Acad. Child Adolesc. Psychiatry43(4), 420–429 (2004).
   PubMed Web of Science ®Google Scholar
• Schubiner H, Saules KK, Arfken CL et al. Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp. Clin. Psychopharmacol.10(3), 286–294 (2002).
   PubMed Web of Science ®Google Scholar
• Levin FR, Evans SM, McDowell DM, Brooks DJ, Nunes E. Bupropion treatment for cocaine abuse and adult attention- deficit/hyperactivity disorder. J. Addict. Dis.21(2), 1–16 (2002).
   PubMed Web of Science ®Google Scholar
• Upadhyaya HP, Brady KT, Sethuraman G, Sonne SC, Malcolm R. Venlafaxine treatment of patients with comorbid alcohol/cocaine abuse and attention-deficit/hyperactivity disorder: a pilot study. J. Clin. Psychopharmacol.21(1), 116–118 (2001).
   PubMed Web of Science ®Google Scholar
• Prince J, Wilens T, Waxmonsky J et al. An open study of sustained-release bupropion in adults with ADHD and substance use disorders. In: Scientific Proceedings of the American Psychiatric Association:New Clinical Drug Evaluation Unit (NCDEU), NR, USA. 222 (2002).
   Google Scholar
• Riggs PD, Leon SL, Mikulich SK, Pottle LC. An open trial of bupropion for ADHD in adolescents with substance abuse disorders and conduct disorder. J. Am. Acad. Child Adolesc. Psychiatry37(12), 1271–1278 (1998).
   PubMed Web of Science ®Google Scholar
• Wilens TE, Monuteaux MC, Snyder LE et al. The clinical dilemma of using medications in substance-abusing adolescents and adults with attention-deficit/hyperactivity disorder: what does the literature tell us? J. Child Adolesc. Psychopharmacol.15, 787–779 (2005).
   PubMed Web of Science ®Google Scholar
• Drug Enforcement Administration. Methylphenidate review document. Washington, DC DEA Office of Diversion Control, Drug and Chemical Evaluation Section (1995).
   Google Scholar
• Langer DH, Sweeney KP, Bartenbach DE, Davis PM, Menander KB. Evidence of lack of abuse or dependence following pemoline treatment: results of a retrospective survey. Drug Alcohol Depend.17, 213–227 (1986).
   PubMed Web of Science ®Google Scholar
• Riggs PD. Clinical approach to treatment of ADHD in adolescents with substance use disorders and conduct disorder. J. Am. Acad. Child Adolesc. Psychiatry37(3), 331–332 (1998).
   PubMed Web of Science ®Google Scholar